Hypoglycaemia and counter-regulation in type 2 diabetes

Lancet

Volumn 356, Issue 9246, 2000, Pages 1946-1947

  Gerich, John E ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; GLIBENCLAMIDE; GLUCAGON; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN; MEGLITINIDE; ORAL ANTIDIABETIC AGENT; REPAZLINIDE; UNCLASSIFIED DRUG;

GLUCAGON RELEASE; GLUCOSE HOMEOSTASIS; HORMONAL REGULATION; HUMAN; HYDROCORTISONE RELEASE; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; BLOOD; GLUCOSE BLOOD LEVEL; METABOLISM;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIA;

EID: 0034627099     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03303-1     Document Type: Note

References (22)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus
2. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin- dependent diabetes mellitus: A randomized prospective 6-year study
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
4. Complications in IDDM are caused by elevated blood glucose level: The Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up
5. Banting Lecture: Hypoglycemia, the limiting factor in the management of IDDM
6. Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study
7. Veterans Affairs cooperative study on glycemic control and complications in type II diabetes (VA CSDM): Results of the feasibility trial
8. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: A randomized clinical trial
9. Rates of hypoglycemia in users of sulfonylureas
10. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction
11. Counterregulatory failure
12. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy
13. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia
14. Effect of hypoglycemia on b-adrenergic sensitivity in normal and type 1 diabetic subjects
15. Hypoglycemia unawareness
16. Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus
17. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus
18. Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM
19. Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes
20. Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes
21. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics
22. Frequency and symptoms of hypoglycemia experienced by patients with type 2 diabetes treated with insulin